Evologic is a spin-off from the Technical University of Vienna, develops novel production methods (bioprocess) for biostimulants. The strong background in pharmaceutical process development is the core of Evologic´s competitive edge. This origin allows transferring advanced processing technologies from pharmaceutical production processes to maximize productivity and product quality of biostimulant production. Evologic is backed by investors from the seed industry (seed distributors) representing 16% of the seed market in central Europe, offering direct access to the seed market. Our core expertise in combination with our current shareholder structure makes Evologic´s position unique in the biostimulant market. To fill our product and technology pipeline, Evologic offers cutting edge bioprocess development and upscaling as a service, primarily to innovative SMEs. Highly innovative SMEs will be offered a substantial discount for process development in exchange for intellectual property rights. This approach will allow Evologic to establish a portfolio of platform technologies for the production of challenging bioactives for agriculture.